[HER2 status in gastric adenocarcinoma of Chinese: a multicenter study of 40 842 patients].
2018 · PubMed · 6 citations
https://doi.org/10.3760/cma.j.issn.0529-5807.2018.11.002
X
Xin Nie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
125
Papers
603
Citations
14
h-index
21
i10-index
Xin Nie is an academic researcher from Hubei University of Medicine. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Diagnosis and Treatment. The author has an h-index of 14, co-authored 107 publications.
ORCID: 0000-0003-2759-2950Papers by this author
worksDeregulated methylation and expression of PCDHGB7 in patients with non-small cell lung cancer: a novel prognostic and immunological biomarker
2025 · Frontiers in Immunology · 2 citations
https://doi.org/10.3389/fimmu.2025.1516628
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients
2025 · BMC Cancer · 2 citations
https://doi.org/10.1186/s12885-025-13775-z
Additional file 4 of N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19386699
Additional file 2 of N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19386693
Additional file 3 of N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19386696
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat